| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/09/1994 | US5336615 Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity |
| 08/09/1994 | US5336603 CD4 adheson variants |
| 08/09/1994 | US5336601 Enzymatic membrane method for the snythesis and separation of peptides |
| 08/09/1994 | US5336595 Determining the body fluid concentration of substance P antagonists in arthritis patients |
| 08/09/1994 | US5336492 Bacillus thuringiensis isolates denoted B.T. PS81F, active against lepidopteran pests |
| 08/09/1994 | US5336491 Using Pasteurella haemolytica antigen |
| 08/09/1994 | US5336256 Tetrapeptide and pentapeptide repeating units; elasticity |
| 08/09/1994 | CA1331419C Peptides with pharmaceutical activity |
| 08/09/1994 | CA1331356C Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 08/09/1994 | CA1331355C Immunopotentation |
| 08/06/1994 | CA2088878A1 Cdnas encoding the gastrin and cck-b receptors |
| 08/05/1994 | CA2114754A1 Acridinium compounds and conjugates thereof |
| 08/05/1994 | CA2114686A1 Mammalian influx peptide transporter |
| 08/04/1994 | WO1994017415A1 Novel anticoagulant cofactor activity |
| 08/04/1994 | WO1994017411A1 Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
| 08/04/1994 | WO1994017407A1 Cell line and assay to determine biological activity of retinoids |
| 08/04/1994 | WO1994017403A1 Non-denaturing potency assay for bovine somatotropin |
| 08/04/1994 | WO1994017197A1 ANTIBODY AGAINST β-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF |
| 08/04/1994 | WO1994017196A1 Detection and treatment of mutations in a cd40 ligand gene |
| 08/04/1994 | WO1994017194A1 Nematode-resistant transgenic plants |
| 08/04/1994 | WO1994017193A2 Chimeric l- and p-selectin by exchange of domains - uses thereof |
| 08/04/1994 | WO1994017192A2 Lysosomal targeting of immunogens |
| 08/04/1994 | WO1994017191A2 Protein fusions for the translocation of apo-proteins into the periplasmic space |
| 08/04/1994 | WO1994017187A1 CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, Pfs230 |
| 08/04/1994 | WO1994017186A1 Novel genes, polypeptides, and compositions for cold tolerance and drought resistance in plants |
| 08/04/1994 | WO1994017185A1 G-csf analog compositions and methods |
| 08/04/1994 | WO1994017184A1 Modulation of physiological responses of lymphocytes by cd38 or antibodies thereto |
| 08/04/1994 | WO1994017183A1 Agents for the prevention and treatment of lesch-nyhan syndrome |
| 08/04/1994 | WO1994017182A1 The l-plastin promoter region and its uses |
| 08/04/1994 | WO1994017103A1 Streptococcus suis adhesin protein and method for producing it |
| 08/04/1994 | WO1994017102A1 Human spasmolytic polypeptide in glycosylated form |
| 08/04/1994 | WO1994017101A1 Max-interacting proteins and related molecules and methods |
| 08/04/1994 | WO1994017100A1 Icam-related protein |
| 08/04/1994 | WO1994017099A2 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 08/04/1994 | WO1994017097A1 Synthetic fibronectin fragments as inhibitors of retroviral infections |
| 08/04/1994 | WO1994017095A1 Analogs of receptor tyrosine activation motifs and therapeutic uses thereof |
| 08/04/1994 | WO1994017087A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | WO1994016737A1 Compositions and methods for delivery of genetic material |
| 08/04/1994 | WO1994016726A1 Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor |
| 08/04/1994 | WO1994016723A2 Wound healing composition |
| 08/04/1994 | WO1994016722A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | WO1994016721A1 Methods of treatment using ciliary neurotrophic factor |
| 08/04/1994 | WO1994016718A1 Genetic modification of neural stem cells |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |
| 08/04/1994 | WO1994016713A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | WO1994016570A1 Production of human recombinant collagen in the milk of transgenic animals |
| 08/04/1994 | WO1994016565A1 Aprotinin and synergistic combinations thereof with lectins as larvicides against insect pests of agronomic crops, harvested material thereof, and products obtained from the harvested material |
| 08/04/1994 | WO1994016557A1 Transgenic animal model system for human cutaneous melanoma |
| 08/04/1994 | WO1994016556A1 Transgenic mammals |
| 08/04/1994 | WO1994016550A1 Tomato spotted wilt virus |
| 08/04/1994 | WO1994013825A3 A disease resistance gene from maize as a selectable marker and gene identification probe |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | WO1994013785A3 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 08/04/1994 | WO1994012650A3 Activating expression of an amplifying endogenous gene by homologous recombination |
| 08/04/1994 | WO1994012637A3 Novel human amyloid protein precursor homologue and kunitz-type inhibitors |
| 08/04/1994 | WO1994005700A3 Methods and reagents to detect and characterize norwalk and related viruses |
| 08/04/1994 | WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof |
| 08/04/1994 | CA2154882A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | CA2154794A1 Non-denaturing potency assay for bovine somatotropin |
| 08/04/1994 | CA2154695A1 Tomato spotted wilt virus |
| 08/04/1994 | CA2154576A1 Aprotinin and synergistic combinations thereof with lectins as larvicides against insect pests of agronomic crops, harvested material thereof, and products obtained from the harvested material |
| 08/04/1994 | CA2154468A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | CA2154171A1 Max-interacting proteins and related molecules and methods |
| 08/04/1994 | CA2154078A1 Wound healing composition |
| 08/04/1994 | CA2153802A1 Chimeric selectins as simultaneous blocking agents for component selectin function |
| 08/04/1994 | CA2153502A1 Transgenic mammals |
| 08/04/1994 | CA2132871A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | CA2132637A1 Icam-related protein |
| 08/03/1994 | EP0608696A2 Heterologous signal sequences for secretion of insect controlling proteins |
| 08/03/1994 | EP0608546A2 Glia activating factor (GAF), antibodies against it and their uses |
| 08/03/1994 | EP0608532A2 Mechanism-based screen for retinoid X receptor agonists and antagonists |
| 08/03/1994 | EP0608334A1 Sperm surface protein |
| 08/03/1994 | EP0608261A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 08/03/1994 | EP0608260A1 Peptide inhibitors of inflammation mediated by selectins |
| 08/03/1994 | EP0608212A1 Method of treating viral infection |
| 08/03/1994 | EP0474744B1 Pdgf -alpha- receptor |
| 08/03/1994 | EP0220234B1 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV |
| 08/03/1994 | CN1090326A Mammalian receptors for interleukin-10 (IL-10) |
| 08/03/1994 | CN1090324A Preparation of surface antigen of recombinant of B hepatitis |
| 08/03/1994 | CN1090289A Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 08/02/1994 | US5334707 Use of acyl phosphate esters in the modification of hemoglobin |
| 08/02/1994 | US5334705 Blood substitutes |
| 08/02/1994 | US5334704 Glycoprotein isolated from ganoderma having immunosuppressive activity |
| 08/02/1994 | US5334702 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 08/02/1994 | US5334584 Recombinant, non-glycosylated bpi protein and uses thereof |
| 08/02/1994 | US5334532 PDGF-B fusion protein, vectors, and host cells for use in production thereof |
| 08/02/1994 | US5334531 Plasmid vector for expression in bacillus and used for cloning the structural gene which codes for the human growth hormone and a method of producing the hormone |
| 08/02/1994 | US5334512 Genetic engineering |
| 08/02/1994 | US5334511 Microorganism escherichia contains recombiant DNA, culturing |
| 08/02/1994 | US5334499 Methods of extracting, amplifying and detecting a nucleic acid from whole blood or PBMC fraction |
| 08/02/1994 | US5334395 Method of treating an epstein-barr viral infection |
| 08/02/1994 | US5334394 A core particle with a surface coatings consisting of maltose, cellobiose, trehalose, isomaltose, nystose, maltotriose and nitrocellulose, bonding with immobilized virus cells; aids vaccines |
| 08/02/1994 | US5334391 Intracellularly cleavable compounds |
| 08/02/1994 | US5334384 Treating the protein mixture with reducing agent to reduce disulfide bridge to free thiol group, which reacts with a reagent, separating modified protein impurity by filtration, sedimentation, centrifuging or retention within chromatography |
| 08/02/1994 | US5334382 Lyophilized polyethylene oxide modified catalase composition, polypeptide complexes with cyclodextrin and treatment of diseases with the catalase compositions |
| 08/02/1994 | US5334379 Cytokine and hormone carriers for conjugate vaccines |
| 08/02/1994 | CA1331157C Method for producing factor viii:c-type proteins |
| 08/02/1994 | CA1331155C Baculovirus transfer vectors |
| 08/02/1994 | CA1331134C Purification of pertussis toxins |
| 07/30/1994 | CA2088379A1 Biological systems incorporating stress-inducible genes and reporter constructs for environmental biomonitoring and toxicology |